PRNewsWire
24 Oct 2025, 13:00 UTC · 51w ago
Shareholders of LifeMD, Inc. Should Contact Levi & Korsinsky Before October 27, 2025 to Discuss Your Rights - LFMD
Impact · against what's priced in
LifeMD faces potential downward pressure as a class action lawsuit alleges the company misled investors regarding its competitive position and understated customer acquisition costs for obesity drugs. Globant is mentioned only in a separate alert, making the news immaterial to its current valuation.
- LFMD−0.60
No priced-in read yet





